Claire E. Moore - Concepedia

Author

Claire E. Moore

Also Known As

C Moore, C. E. J. Moore, C. E. Moore, C. Moore, Claire E J Moore, Claire E Moore, Claire E. J. Moore, Claire E. Moore, Claire E.J. Moore, Claire Moore

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Leicester University of Southampton University of Utah South Australian Health and Medical Research Institute Unilever (United Kingdom)

About

Claire E. Moore is an author at University of Leicester specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	528
2	Engineering	2	2	80
3	Allergy	2	2	159
4	Health Sciences	1	1	73
5	Natural Sciences	1	1	24

Claire E. Moore

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Eukaryotic Elongation Factor 2 Kinase Activity Is Controlled by Multiple Inputs from Oncogenic Signaling Xuemin Wang, Sergio Regufe da Mota, Rui Liu, Molecular and Cellular Biology Mtorc1 And/or ErkTumor BiologyTranscriptional RegulationSignaling PathwayCell Regulation	2014	102
Use of Human In Vitro Skin Models for Accurate and Ethical Risk Assessment: Metabolic Considerations Nicola J. Hewitt, Robert J. Edwards, Ellen Fritsche, Toxicological Sciences DermatologyOxidative StressBioanalysisNative Human SkinMetabolic Engineering	2013	101
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2) Adam D. Barlow, Jianling Xie, Claire E. Moore, Diabetologia	2012	74
Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia Claire E. Moore, Halina Mikolajek, Sergio Regufe da Mota, Molecular and Cellular Biology Kinase IsRedox BiologyCellular PhysiologyProtein SynthesisOxidative Stress	2015	73
cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity Jianling Xie, Godwin A. Ponuwei, Claire E. Moore, Cellular Signalling	2011	69
PERK Activation at Low Glucose Concentration Is Mediated by SERCA Pump Inhibition and Confers Preemptive Cytoprotection to Pancreatic β-Cells Claire E. Moore, Omotola Omikorede, Edith Gomez, Molecular Endocrinology	2010	63
The Cosmetics Europe strategy for animal-free genotoxicity testing: Project status up-date Stefan Pfuhler, Rolf Fautz, Gladys Ouédraogo, Toxicology in Vitro EngineeringToxicology TestingDermatologyLaboratory Animal StudyEnvironmental Health	2013	58
Identification of cAMP-Dependent Kinase as a Third in Vivo Ribosomal Protein S6 Kinase in Pancreatic β-Cells Claire E. Moore, Jianling Xie, Edith Gomez, Journal of Molecular Biology Pancreatic β-CellsCamp-dependent KinaseSignal TransductionMolecular PhysiologyCell Regulation	2009	54
Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains Craig R. Pigott, Halina Mikolajek, Claire E. Moore, Biochemical Journal	2011	46
Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival Jianling Xie, Halina Mikolajek, Craig R. Pigott, Molecular and Cellular Biology	2015	45

Page 1